Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115:1886–1892
2. Galanello R, Piras S, Barella S, Leoni GB, Cipollina MD, Perseu L, Cao A (2001) Cholelithiasis and Gilbert’s syndrome in homozygous beta-thalassaemia. Br J Haematol 115:926–928
3. Taher A, Musallam K, Cappellini MD. Guidelines for the management of non transfusion dependent thalassaemia (NTDT) [Internet]. 2017 [cited 2020 May 31]. Available from: https://ulib.aub.edu.lb/febk/febk000673-b22071052.pdf
4. Gardenghi S, Marongiu MF, Ramos P, Guy E, Breda L, Chadburn A, Liu Y, Amariglio N, Rechavi G, Rachmilewitz EA, Breuer W, Cabantchik ZI, Wrighting DM, Andrews NC, de Sousa M, Giardina PJ, Grady RW, Rivella S (2007) Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109:5027–5035
5. Santos PC, Dinardo CL, Cançado RD, Schettert IT, Krieger JE, Pereira AC (2012) Non-HFE hemochromatosis. Rev Bras HematolHemoter 34:311–316
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献